CollPlant Biotechnologies (CLGN) EBIT Margin Growth (1y) (2018 - 2026)
CollPlant Biotechnologies (CLGN) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -418,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -418,693.00 |
| Dec 31, 2025 | -282,683.00 |
| Sep 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 594.00 |
| Mar 30, 2025 | -449,754.00 |
| Dec 31, 2024 | -72,819.00 |
| Sep 30, 2024 | -11.35 Mn |
| Jun 30, 2024 | 171,373.00 |
| Mar 31, 2024 | 360,464.00 |
| Dec 31, 2023 | 636,709.00 |
| Sep 30, 2023 | 409,907.00 |
| Jun 30, 2023 | 639,665.00 |
| Dec 31, 2022 | -683,497.00 |
| Sep 30, 2022 | -188,908.00 |
| Jun 30, 2022 | -589,764.00 |
| Dec 31, 2021 | -113,583.00 |
| Sep 30, 2021 | -222,770.00 |
| Jun 30, 2021 | -21,083.00 |
| Mar 31, 2021 | 34,944.00 |
| Dec 31, 2020 | 50,007.00 |